Blockade of interleukin-6 effects on cytokine profiles and macrophage activation after spinal cord injury in mice

Alexander Rodriguez Guerrero, Kenzo Uchida, Hideaki Nakajima, Shuji Watanabe, Masaya Nakamura, Seiji Okada, William E B Johnson, Hisatoshi Baba

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The objective of this study was to clarify the effects of a temporal blockade of IL-6/IL-6 receptor (IL-6R) engagement, using an anti-mouse IL-6R monoclonal antibody (MR16-1), on macrophage activation and the inflammatory response in the acute phase after spinal cord injury (SCI) in mice. MR16-1 antibodies versus isotype control antibodies or saline alone was administered immediately after thoracic SCI in mice. MR16-1-treated group samples showed increased neuronal regeneration and locomotor recovery compared with controls. Immunoblot analysis of the MR16-1-treated samples identified downregulation of Th1 and upregulation of Th2 cytokines. MR16-1 treatment promoted arginase-1-positive, CD206-positive M2 macrophages, with preferential localization of these cells at the injury site and enhanced positivity for Mac-2 and Mac-3, suggestive of increased phagocytic behavior. The results suggest that temporal blockade of IL-6 signaling after SCI abrogates damaging inflammatory activity and promotes functional recovery by promoting the formation of alternatively activated M2 macrophages.

Original languageEnglish
Title of host publicationNeuroprotection and Regeneration of the Spinal Cord
PublisherSpringer Japan
Pages203-212
Number of pages10
Volume9784431545026
ISBN (Print)9784431545026, 4431545018, 9784431545019
DOIs
Publication statusPublished - 2013 Nov 1

Fingerprint

Macrophage Activation
Spinal Cord Injuries
Interleukin-6 Receptors
Interleukin-6
Cytokines
Macrophages
Arginase
Thoracic Injuries
Acute-Phase Reaction
Antibodies
Regeneration
Up-Regulation
Down-Regulation
Monoclonal Antibodies
Wounds and Injuries

Keywords

  • Alternatively activated macrophage
  • Interleukin (IL)-6/IL-6 receptor (R)
  • Spinal cord injury
  • T helper (Th) cytokine

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Guerrero, A. R., Uchida, K., Nakajima, H., Watanabe, S., Nakamura, M., Okada, S., ... Baba, H. (2013). Blockade of interleukin-6 effects on cytokine profiles and macrophage activation after spinal cord injury in mice. In Neuroprotection and Regeneration of the Spinal Cord (Vol. 9784431545026, pp. 203-212). Springer Japan. https://doi.org/10.1007/978-4-431-54502-6_17

Blockade of interleukin-6 effects on cytokine profiles and macrophage activation after spinal cord injury in mice. / Guerrero, Alexander Rodriguez; Uchida, Kenzo; Nakajima, Hideaki; Watanabe, Shuji; Nakamura, Masaya; Okada, Seiji; Johnson, William E B; Baba, Hisatoshi.

Neuroprotection and Regeneration of the Spinal Cord. Vol. 9784431545026 Springer Japan, 2013. p. 203-212.

Research output: Chapter in Book/Report/Conference proceedingChapter

Guerrero, AR, Uchida, K, Nakajima, H, Watanabe, S, Nakamura, M, Okada, S, Johnson, WEB & Baba, H 2013, Blockade of interleukin-6 effects on cytokine profiles and macrophage activation after spinal cord injury in mice. in Neuroprotection and Regeneration of the Spinal Cord. vol. 9784431545026, Springer Japan, pp. 203-212. https://doi.org/10.1007/978-4-431-54502-6_17
Guerrero AR, Uchida K, Nakajima H, Watanabe S, Nakamura M, Okada S et al. Blockade of interleukin-6 effects on cytokine profiles and macrophage activation after spinal cord injury in mice. In Neuroprotection and Regeneration of the Spinal Cord. Vol. 9784431545026. Springer Japan. 2013. p. 203-212 https://doi.org/10.1007/978-4-431-54502-6_17
Guerrero, Alexander Rodriguez ; Uchida, Kenzo ; Nakajima, Hideaki ; Watanabe, Shuji ; Nakamura, Masaya ; Okada, Seiji ; Johnson, William E B ; Baba, Hisatoshi. / Blockade of interleukin-6 effects on cytokine profiles and macrophage activation after spinal cord injury in mice. Neuroprotection and Regeneration of the Spinal Cord. Vol. 9784431545026 Springer Japan, 2013. pp. 203-212
@inbook{21f55aa4627a45a6a76573fa6e9cb6fb,
title = "Blockade of interleukin-6 effects on cytokine profiles and macrophage activation after spinal cord injury in mice",
abstract = "The objective of this study was to clarify the effects of a temporal blockade of IL-6/IL-6 receptor (IL-6R) engagement, using an anti-mouse IL-6R monoclonal antibody (MR16-1), on macrophage activation and the inflammatory response in the acute phase after spinal cord injury (SCI) in mice. MR16-1 antibodies versus isotype control antibodies or saline alone was administered immediately after thoracic SCI in mice. MR16-1-treated group samples showed increased neuronal regeneration and locomotor recovery compared with controls. Immunoblot analysis of the MR16-1-treated samples identified downregulation of Th1 and upregulation of Th2 cytokines. MR16-1 treatment promoted arginase-1-positive, CD206-positive M2 macrophages, with preferential localization of these cells at the injury site and enhanced positivity for Mac-2 and Mac-3, suggestive of increased phagocytic behavior. The results suggest that temporal blockade of IL-6 signaling after SCI abrogates damaging inflammatory activity and promotes functional recovery by promoting the formation of alternatively activated M2 macrophages.",
keywords = "Alternatively activated macrophage, Interleukin (IL)-6/IL-6 receptor (R), Spinal cord injury, T helper (Th) cytokine",
author = "Guerrero, {Alexander Rodriguez} and Kenzo Uchida and Hideaki Nakajima and Shuji Watanabe and Masaya Nakamura and Seiji Okada and Johnson, {William E B} and Hisatoshi Baba",
year = "2013",
month = "11",
day = "1",
doi = "10.1007/978-4-431-54502-6_17",
language = "English",
isbn = "9784431545026",
volume = "9784431545026",
pages = "203--212",
booktitle = "Neuroprotection and Regeneration of the Spinal Cord",
publisher = "Springer Japan",

}

TY - CHAP

T1 - Blockade of interleukin-6 effects on cytokine profiles and macrophage activation after spinal cord injury in mice

AU - Guerrero, Alexander Rodriguez

AU - Uchida, Kenzo

AU - Nakajima, Hideaki

AU - Watanabe, Shuji

AU - Nakamura, Masaya

AU - Okada, Seiji

AU - Johnson, William E B

AU - Baba, Hisatoshi

PY - 2013/11/1

Y1 - 2013/11/1

N2 - The objective of this study was to clarify the effects of a temporal blockade of IL-6/IL-6 receptor (IL-6R) engagement, using an anti-mouse IL-6R monoclonal antibody (MR16-1), on macrophage activation and the inflammatory response in the acute phase after spinal cord injury (SCI) in mice. MR16-1 antibodies versus isotype control antibodies or saline alone was administered immediately after thoracic SCI in mice. MR16-1-treated group samples showed increased neuronal regeneration and locomotor recovery compared with controls. Immunoblot analysis of the MR16-1-treated samples identified downregulation of Th1 and upregulation of Th2 cytokines. MR16-1 treatment promoted arginase-1-positive, CD206-positive M2 macrophages, with preferential localization of these cells at the injury site and enhanced positivity for Mac-2 and Mac-3, suggestive of increased phagocytic behavior. The results suggest that temporal blockade of IL-6 signaling after SCI abrogates damaging inflammatory activity and promotes functional recovery by promoting the formation of alternatively activated M2 macrophages.

AB - The objective of this study was to clarify the effects of a temporal blockade of IL-6/IL-6 receptor (IL-6R) engagement, using an anti-mouse IL-6R monoclonal antibody (MR16-1), on macrophage activation and the inflammatory response in the acute phase after spinal cord injury (SCI) in mice. MR16-1 antibodies versus isotype control antibodies or saline alone was administered immediately after thoracic SCI in mice. MR16-1-treated group samples showed increased neuronal regeneration and locomotor recovery compared with controls. Immunoblot analysis of the MR16-1-treated samples identified downregulation of Th1 and upregulation of Th2 cytokines. MR16-1 treatment promoted arginase-1-positive, CD206-positive M2 macrophages, with preferential localization of these cells at the injury site and enhanced positivity for Mac-2 and Mac-3, suggestive of increased phagocytic behavior. The results suggest that temporal blockade of IL-6 signaling after SCI abrogates damaging inflammatory activity and promotes functional recovery by promoting the formation of alternatively activated M2 macrophages.

KW - Alternatively activated macrophage

KW - Interleukin (IL)-6/IL-6 receptor (R)

KW - Spinal cord injury

KW - T helper (Th) cytokine

UR - http://www.scopus.com/inward/record.url?scp=84930707556&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930707556&partnerID=8YFLogxK

U2 - 10.1007/978-4-431-54502-6_17

DO - 10.1007/978-4-431-54502-6_17

M3 - Chapter

AN - SCOPUS:84930707556

SN - 9784431545026

SN - 4431545018

SN - 9784431545019

VL - 9784431545026

SP - 203

EP - 212

BT - Neuroprotection and Regeneration of the Spinal Cord

PB - Springer Japan

ER -